CNA Financial Corporation (CNA) Stock Forecast
Data as of Nov 1, 2026Financial Services · Current price $48.65 (-0.49%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Jul 30, 2024 | Joshua Shanker | Bank of America Securities | $45.00 | -7.5% |
Top Analysts Covering CNA
CNA vs Sector & Market
| Metric | CNA | Financial Services Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | — | 2.51 | 2.41 |
| Analyst Count | — | 9 | 19 |
| Target Upside | -7.5% | +133.0% | +21.5% |
| P/E Ratio | 10.88 | -4.33 | 38.49 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $3.05B | $3.05B | $3.05B | 1 |
| 2027-12-31 | $14.43B | $14.43B | $14.43B | 5 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $1.13 | $1.13 | $1.13 | 1 |
| 2027-12-31 | $5.25 | $5.25 | $5.25 | 3 |
Frequently Asked Questions
What is the analyst consensus for CNA?
The consensus among 0 analysts covering CNA Financial Corporation (CNA) is — with an average price target of $45.00.
What is the highest price target for CNA?
The highest price target for CNA is $45.00, set by Joshua Shanker at Bank of America Securities on 2024-07-30.
What is the lowest price target for CNA?
The lowest price target for CNA is $45.00, set by Joshua Shanker at Bank of America Securities on 2024-07-30.
How many analysts cover CNA?
0 analysts have issued ratings for CNA Financial Corporation in the past 12 months.
Is CNA a buy or sell right now?
Based on 0 analyst ratings, CNA has a consensus rating of — with a -7.5% upside to the consensus target of $45.00.
What are the earnings estimates for CNA?
Analysts estimate CNA will report EPS of $1.13 for the period ending 2026-12-31, with revenue estimated at $3.05B.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.